PHARMACEUTICAL ECONSULTING A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About PHARMACEUTICAL ECONSULTING A/S
PHARMACEUTICAL ECONSULTING A/S (CVR number: 30815378) is a company from ALBERTSLUND. The company recorded a gross profit of 5538 kDKK in 2024. The operating profit was -941.3 kDKK, while net earnings were -643.9 kDKK. The profitability of the company measured by Return on Assets (ROA) was -9.7 %, which can be considered poor and Return on Equity (ROE) was -9.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 70.6 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. PHARMACEUTICAL ECONSULTING A/S's liquidity measured by quick ratio was 3.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 6 946.67 | 8 276.39 | 6 778.72 | 5 578.65 | 5 538.00 |
EBIT | 2 977.65 | 3 050.41 | 770.09 | - 394.89 | - 941.30 |
Net earnings | 2 345.13 | 2 419.81 | 779.62 | - 383.63 | - 643.85 |
Shareholders equity total | 4 047.62 | 6 467.43 | 7 247.05 | 6 863.42 | 6 219.57 |
Balance sheet total (assets) | 17 131.99 | 19 657.84 | 8 092.29 | 7 990.63 | 8 806.14 |
Net debt | 8 337.60 | 6 989.45 | -59.53 | - 351.35 | 1 189.09 |
Profitability | |||||
EBIT-% | |||||
ROA | 20.8 % | 18.2 % | 9.0 % | -3.3 % | -9.7 % |
ROE | 69.5 % | 46.0 % | 11.4 % | -5.4 % | -9.8 % |
ROI | 39.4 % | 22.3 % | 10.6 % | -3.8 % | -11.0 % |
Economic value added (EVA) | 2 186.86 | 2 242.38 | 413.08 | - 860.51 | -1 006.10 |
Solvency | |||||
Equity ratio | 23.6 % | 32.9 % | 89.6 % | 85.9 % | 70.6 % |
Gearing | 240.7 % | 151.7 % | 0.2 % | 27.4 % | |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1.3 | 1.5 | 9.4 | 7.0 | 3.3 |
Current ratio | 1.3 | 1.5 | 9.4 | 7.0 | 3.3 |
Cash and cash equivalents | 1 406.32 | 2 824.62 | 59.53 | 363.13 | 515.48 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BBB | A | BBB | BBB | BBB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.